Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy decisions in leukemia.

K A Atkinson1, M M Horowitz, K A Sobocinski

  • 1International Bone Marrow Transplant Registry, Medical College of Wisconsin, Milwaukee 53226.

Bone Marrow Transplantation
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sharing Data in Biomedical Research.

Leukemia & lymphoma·2016
Same author

Rubella in pregnancy causing malformations in newborn.

Journal of the American Medical Association·2010
Same author

The potential usefulness of a differentiating teratocarcinoma cell line in in vitro toxicity testing.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Development of a fixed-dose approach for the fluorescein leakage test.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.

Experimental hematology·2001
Same author

Effects of alcohol-related disease on hip fracture and mortality: a retrospective cohort study of hospitalized Medicare beneficiaries.

American journal of public health·2001
Same journal

Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen.

Bone marrow transplantation·2026
Same journal

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same journal

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Bone marrow transplantation·2026
Same journal

Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT.

Bone marrow transplantation·2026
Same journal

Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

Bone marrow transplantation·2026
Same journal

A multimodal sexual health intervention among hematopoietic stem cell transplant recipients: mediating effects on quality of life and mood.

Bone marrow transplantation·2026
See all related articles

Physician treatment decisions for leukemia are complex. Experts showed consensus on general policies but differed on specific cases, sometimes contradicting published research.

Area of Science:

  • Hematology
  • Oncology
  • Medical Decision-Making

Background:

  • Physician treatment selection involves complex factors.
  • Optimal leukemia treatment strategies require expert consensus.
  • Understanding factors influencing therapy choices is crucial.

Purpose of the Study:

  • To determine consensus among leukemia experts on optimal treatment.
  • To identify factors correlated with therapy decisions.
  • To compare treatment recommendations across different expert groups.

Main Methods:

  • Survey of 352 leukemia experts.
  • Evaluation of general treatment policies and specific clinical scenarios.
  • Comparison of responses from chemotherapy, allotransplant, and autotransplant experts.

Related Experiment Videos

Main Results:

  • Expert groups showed similar general treatment policies.
  • Recommendations for specific clinical situations differed substantially among expert groups.
  • Expert recommendations sometimes diverged from published study conclusions.

Conclusions:

  • Expert consensus exists for general leukemia treatment policies.
  • Specific clinical scenarios reveal significant differences in expert recommendations.
  • Experts may prioritize personal experience or perceived optimal strategies over published data.